A61P 35 - Antineoplastic agents

Patents for A61P 35 - Antineoplastic agents (221,099)
11/2004
11/25/2004	US20040235741 Human papilloma virus treatment
11/25/2004	US20040235723 Introducing ABC protein gene into yeast cell having high drug sensitivity to prepare transformed cell where protein is expressed in cell membrane, incubating cell in presence of test substance and substance which is subjected to active transfer outside cell by ABC protein in cell membrane, comparing
11/25/2004	US20040235722 Assay that makes use of the interaction of early pregnancy factor (EPF) or an EPF-related peptide with a human dorsal root receptor (hDRR) or hDRR related receptor; also useful to determine whether the test compound is an agonist or antagonist of hDRRs
11/25/2004	US20040235175 Method for transfection of rna using electrical pulses
11/25/2004	US20040235171 Using post-transcriptional silencing to treat cell proliferative disorders associated with human papiloma viral infection; RNA interference; antitumor/antiviral agents
11/25/2004	US20040235156 Therapeutic mixture comprising interferons and chimeric immunoglobulins for use in activation of immune response and treatment, diagnosis and prevention of cancer; immunotherapy; tissue targeted therapy
11/25/2004	US20040235129 KDEL receptor inhibitors
11/25/2004	US20040235117 Fusion protein comprised of t umor necrosis factor, cartilage oligomeric and cartliage matrix protein domains for use in identifying modulator for treatment of infections, autoimmue, cell proliferative, neurodegenerative and inflammatory diseases
11/25/2004	US20040235108 Immunoglobulin which competitively binds tetrameric form of the alpha-folate receptor for use in treatment and prevention of cell proliferfative disorders; immunotherapy
11/25/2004	US20040235106 18891, a novel human lipase
11/25/2004	US20040235095 Proaerolysin containing protease activation sequences and methods of use for treatment of prostate cancer
11/25/2004	US20040235074 Methods for the treatment or prevention of immune disorders using anti-CD40 antibodies
11/25/2004	US20040235072 Compositions and methods for the therapy and diagnosis of lung cancer
11/25/2004	US20040235070 Immune reactivity to expressed activated oncogenes for diagnosis and treatment of malignancy
11/25/2004	US20040235066 Using immunoglobulin specific to cancer testis-antigens for use in diagnosis and treatment of cell proliferative diseaes; immunotherapy
11/25/2004	US20040235065 Alpha-fetoprotein Immu31 antibodies and fusion proteins and methods of use thereof
11/25/2004	US20040235018 Nucleotide sequences coding zinc finger protein for use in identifying modulators of cell proliferation disorders; antitumor agents
11/25/2004	US20040234979 Differentiall-expressed and up-regulated polynucleotides and polypeptides in breast cancer
11/25/2004	US20040234959 Truncated bard1 protein, and its diagnostic and therapeutic uses
11/25/2004	US20040234622 Sulfonamide derivatives
11/25/2004	US20040234587 Biomass; animal extracts; anticancer agents; learning enhancing
11/25/2004	US20040234575 Medical products comprising a haemocompatible coating, production and use thereof
11/25/2004	US20040234545 Aids and leukemia therapy; enhancing immunology response; promote secretion of peptide such as defensin
11/25/2004	US20040234527 Peptides for use as translocation factors
11/25/2004	US20040234526 Use of a compound antagonist of esm-1 protein for producing a medicine for treating cancer
11/25/2004	US20040234520 Uses for Eph receptor antagonists and agonists
11/25/2004	US20040234503 Materials and methods relating to improved vaccinations strategies
11/25/2004	US20040234498 Inducing apoptosis in mammalian cancer cellsl stimulanting a proinflammatory response ; polypeptides; tumor necrosis factor
11/25/2004	US20040234495 Antitumor agents and process for producing the same
11/25/2004	US20040234454 Pathological tissue detection and treatment employing targeted benzoindole optical agents
11/25/2004	DE10318896A1 8beta-Vinyl-11beta-(omega-substituierte)alkyl-estra-1,3,5(10)-triene 8beta-vinyl-11beta- (omega-substituted) alkyl-estra-1,3,5 (10) -trienes
11/25/2004	CA2526025A1 Preventive and/or remedy for diseases accompanied by tissue destruction
11/25/2004	CA2525684A1 Sulfamate benzothiophene derivatives as steroid sulfatase inhibitors
11/25/2004	CA2525438A1 Glyoxalase inhibitors
11/25/2004	CA2525370A1 Domain-exchanged binding molecules, methods of use and methods of production
11/25/2004	CA2524780A1 Compounds for treatment of inflammation, diabetes and related disorders
11/24/2004	EP1480042A2 Method of screening compounds interacting with proteins of the p53 family
11/24/2004	EP1479772A1 Apoptosis promoter and inhibitor interacting with cgi-94 and method of screening the same
11/24/2004	EP1479768A1 Novel screening method
11/24/2004	EP1479764A1 Heparanase-derived peptides for vaccination of tumor patients
11/24/2004	EP1479711A1 Multidrop tree branching functional polyethylene glycol, the preparation method and the use of it
11/24/2004	EP1479696A1 Human monoclonal antibody binding Ep-CAM, and its use in cancer therapy
11/24/2004	EP1479684A1 Thienopyrimidines, process for preparing the same and use thereof
11/24/2004	EP1479398A1 AGENT CONTROLLING THE APOPTOSIS INDUCTION BY p73
11/24/2004	EP1479388A1 Ready to use gemcitabin solution concentrates
11/24/2004	EP1479385A1 Use of cyclooxygenase-2 inhibitors in the treatment and prevention of neoplasia
11/24/2004	EP1478784A2 Method and nucleic acids for the analysis of colorectal cell proliferative disorders
11/24/2004	EP1478782A2 Methods for determining the response of cells to vegf and uses thereof
11/24/2004	EP1478778A2 Method and nucleic acids for the analysis of a colon cell proliferactive disorder
11/24/2004	EP1478773A2 Methods for assessing and treating leukemia
11/24/2004	EP1478764A2 Humanized collagen antibodies and related methods
11/24/2004	EP1478762A2 Nucleic acid-associated proteins
11/24/2004	EP1478756A2 Microorganisms as carriers of nucleotide sequences coding for cell antigens used for the treatment of tumors
11/24/2004	EP1478745A2 Kinases and phosphatases
11/24/2004	EP1478735A1 Methods for inducing the differentiation of monocytes into functional dendritic cells and immunotherapeutic compositions including such dendritic cells
11/24/2004	EP1478731A1 Phenalenone derivatives, method for the production thereof and use of the same
11/24/2004	EP1478667A1 Anti-human tenascin monoclonal antibody
11/24/2004	EP1478664A1 Tissue specific expression
11/24/2004	EP1478661A2 Long pentraxin ptx3 functional derivatives for preparing an autologous vaccine for the treatment of tumours
11/24/2004	EP1478659A2 Biologically active peptides
11/24/2004	EP1478656A2 Oligonucleotide compositions with enhanced efficiency
11/24/2004	EP1478648A2 Phosphorus-containing compounds uses thereof
11/24/2004	EP1478645A2 Quinolinone derivatives for treating cell proliferation related disorders
11/24/2004	EP1478639A1 Fused tricyclic heterocycles useful for treating hyper-proliferative disorders
11/24/2004	EP1478624A1 Chemical compounds
11/24/2004	EP1478620A1 Phenethanolamine derivatives for treatment of respiratory diseases
11/24/2004	EP1478613A2 Substituted 10-aryl-11h-benzo[b]fluorenes and 7-aryl-5,6-dihydro-benz[a]anthracenes for selective effects on estrogen receptors
11/24/2004	EP1478394A2 Polypeptide formulation
11/24/2004	EP1478393A2 Anti-pathogen treatements
11/24/2004	EP1478391A1 Method of providing prophylaxis for tuberculosis in hiv positive individuals
11/24/2004	EP1478381A2 Use of soluble gamma delta t cell receptors for regulating t cell function
11/24/2004	EP1478371A2 Methods and products for enhancing immune responses using imidazoquinoline compounds
11/24/2004	EP1478365A1 Combination consisting of trapidil and serotonin antagonists such as cyproheptadine or pizotifen for inhibiting angiogenesis
11/24/2004	EP1478360A1 Agents which interact with a serotonin transporter for the treatment of cancer
11/24/2004	EP1478358A1 Aryl ureas with angiogenesis inhibiting activity
11/24/2004	EP1478357A2 Tricyclic pyrazole derivatives, process for their preparation and their use as antitumor agents
11/24/2004	EP1478355A2 Antitumor compositions containing taxane derivatives
11/24/2004	EP1478353A1 Sustained release pharmaceutical composition
11/24/2004	EP1478343A2 Compositions and methods for delivery of poorly water soluble drugs and methods of treatment
11/24/2004	EP1478339A1 Pharmaceutical formulations of antineoplastic agents, in particular temozolomide, processes of making and using the same
11/24/2004	EP1478322A2 Beta-2'-OR 3'-HALONUCLEOSIDES
11/24/2004	EP1478276A2 Novel targeted compositions for diagnostic and therapeutic use
11/24/2004	EP1305306B1 2-adamantylethylamines and their use in the treatment of conditions generally associated with abnormalities in glutamatergic transmission
11/24/2004	EP1285000B1 Adnf mixtures for enhancing learning and memory
11/24/2004	EP1272201B1 Use of compatible solutes as substances having free radical scavenging properties
11/24/2004	EP1214078B1 Formulations for parenteral use of estramustine phosphate and amino acids
11/24/2004	EP1185536B1 Hemisynthetic method and intermediates thereof
11/24/2004	EP1183231B1 Cytofectin dimers and methods of use thereof
11/24/2004	EP1176988B1 Radioactive cisplatin in the treatment of cancer
11/24/2004	EP1175214B1 Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect
11/24/2004	EP1171587B1 Peptide from antigen muc-1 for triggering an immune response to tumor cells
11/24/2004	EP1109550B1 Novel nitrophenylaziridine compounds and their use as prodrugs
11/24/2004	EP1107971B1 Porphyrin derivatives, their use in photodynamic therapy and medical devices containing them
11/24/2004	EP1105155B1 Vaccine comprising cytokine-induced heat shock proteins (hsp)
11/24/2004	EP1003496B1 Medicament for treating prostate intraepithelial neoplasia
11/24/2004	EP0946185B1 PHARMACEUTICAL COMPOSITION COMPRISING A COMPOUND HAVING ANTI-Xa ACTIVITY AND A PLATELET AGGREGATION ANTAGONIST COMPOUND
11/24/2004	EP0929538B1 O?2 -arylated or o?2 -glycosylated 1-substituted diazen-1-ium-1,2-diolates and o?2 -substituted 1- (2-carboxylato)pyrrolidin-1-yl]diazen-1-ium-1,2-diolates
11/24/2004	EP0929318B1 Melanoma cell lines expressing shared immunodominant melanoma antigens and methods of using same
11/24/2004	EP0856157B1 Tumour-specific p450 protein
11/24/2004	CN1549824A Peptidic compounds selectively binding to p-selectin

1 ... 1352 1353 1354 1355 1356 1357 1358 1359 1360 1361 1362 1363 1364 1365 1366 1367 1368 1369 1370 1371 1372 ... 2211